# CytoSorb® in Patients With Acute on Chronic Liver Failure

> **NCT05131230** · — · WITHDRAWN · sponsor: **CytoSorbents Europe GmbH**

## Conditions studied

- Acute on Chronic Liver Failure
- Alcoholic Hepatitis

## Interventions

- **DEVICE:** CytoSorb® treatment

## Key facts

- **NCT ID:** NCT05131230
- **Lead sponsor:** CytoSorbents Europe GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-03-15
- **Primary completion:** 2023-03
- **Final completion:** 2023-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients enrolled
- **Last updated:** 2022-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05131230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05131230, "CytoSorb® in Patients With Acute on Chronic Liver Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05131230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*